Q1 2026 · —
Revenue—
Net Income-$45.32M-$45.32M N/M vs Q1 2025N/M vs Q3 2025
EPS, diluted—
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Net Income | -$45.32M | -$38.33M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Parabilis Medicines, Inc. · CIK 1657677 · Engraved from SEC EDGAR